DeveloGen
Latest round
- Series B
Last raised
- Apr 2001
Total raised
- $38M
Investors
- 10
About DeveloGen
Founded in 1997 and based in Goettingen, Germany, DeveloGen AG is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of metabolic and endocrine diseases, focusing on diabetes.
Who invested in DeveloGen
10 investors across 2 rounds
See all investors in DeveloGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DeveloGen
Who invested in DeveloGen?
DeveloGen has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DeveloGen raised?
DeveloGen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DeveloGen last raise money?
DeveloGen's most recent round on record is a Series B, in Apr 2001.
What does DeveloGen do?
Founded in 1997 and based in Goettingen, Germany, DeveloGen AG is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of metabolic and endocrine diseases, focusing on diabetes.
Where is DeveloGen headquartered?
DeveloGen is headquartered in Gottingen, Germany.
Which VCs invest in companies like DeveloGen?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at DeveloGen's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like DeveloGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.